XML 30 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

In connection with management changes, the Company realigned the reporting structure of its skin health business effective July 1, 2024. Accordingly, commencing with the quarter ended September 30, 2024, the results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment, with no impact on the Company’s consolidated results of operations or financial position. The Company recast its historical geographic segment information to conform to the new reporting structure in 2024.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The Chairman of the Board, President and Chief Executive Officer has been determined to be the Company’s Chief Operating Decision Maker and he uses Operating Profit to assess performance and to allocate resources for each of the reportable operating segments in the budgeting and forecasting process. Asset information by segment is not utilized for purposes of assessing performance or allocating resources, and therefore such information has not been presented.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.
Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
Corporate Operating profit (loss) for the three months ended March 31, 2025 included charges related to the ERISA litigation matter of $15. Corporate Operating profit (loss) for the three months ended March 31, 2024 included charges resulting from the 2022 Global Productivity Initiative of $36.
The Company’s net sales, significant segment expenses and operating profit, by reportable segment were:

Three Months Ended March 31, 2025
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (1)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America$998 $377 $415 $10 $196 
Latin America1,143 487 316 (7)348 
Europe690 258 254 7 172 
Asia Pacific690 261 239 (7)198 
Africa/Eurasia271 104 106 4 57 
Total Oral, Personal and Home Care3,792 971 
Pet Nutrition1,118 437 422 1 258 
Reconciliation with Total Company Operating Profit
Corporate(153)
Total$4,911 $1,076 
Note: Table may not sum due to rounding.
(1)Other (income) expense, net primarily includes amortization of intangible assets and equity income.


Three Months Ended March 31, 2024
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (1)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America$1,035 $390 $419 $13 $214 
Latin America1,253 502 345 1 405 
Europe673 267 245 8 153 
Asia Pacific727 284 242 (7)207 
Africa/Eurasia276 106 99 5 66 
Total Oral, Personal and Home Care3,963 1,044 
Pet Nutrition1,102 482 413 9 199 
Reconciliation with Total Company Operating Profit
Corporate(196)
Total$5,065 $1,047 
Note: Table may not sum due to rounding.
(1)Other (income) expense, net primarily includes amortization of intangible assets and equity income.
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:

Three Months Ended
 March 31,
 20252024
Net sales
Oral Care44 %43 %
Personal Care17 %18 %
Home Care16 %17 %
Pet Nutrition23 %22 %
Total Net sales100 %100 %

Capital expenditures and depreciation and amortization expense by segment were:

Three Months Ended
 March 31,
 20252024
Capital expenditures  
Oral, Personal and Home Care 
North America$17 $8 
Latin America28 21 
Europe8 8 
Asia Pacific13 9 
Africa/Eurasia2 1 
Total Oral, Personal and Home Care68 47 
Pet Nutrition21 53 
Corporate35 26 
Total Capital expenditures$124 $126 
Three Months Ended
 March 31,
 20252024
Depreciation and amortization  
Oral, Personal and Home Care  
North America$30 $31 
Latin America24 27 
Europe15 16 
Asia Pacific20 20 
Africa/Eurasia2 2 
Total Oral, Personal and Home Care92 96 
Pet Nutrition31 30 
Corporate25 24 
Total Depreciation and amortization$148 $150 
Note: Table may not sum due to rounding.